Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Shaw

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Nature Methods|July 7, 2014
Spatial control of membrane receptor function using ligand nanocalipersAlan Shaw, Vanessa Lundin, Ekaterina Petrova, et al.
Nature Nanotechnology|January 16, 2019
Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodiesAlan Shaw, Ian T Hoffecker, Ioanna Smyrlaki, et al.
Nature Nanotechnology|February 21, 2019
Publisher Correction: Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodiesAlan Shaw, Ian T Hoffecker, Ioanna Smyrlaki, et al.
Vaccine|October 26, 2010
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adultsJohn J Treanor, David N Taylor, Lynda Tussey, et al.
Virology|January 22, 2005
Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse modelLeigh Zerboni, Stewart Hinchliffe, Marvin H Sommer, et al.
Cancer Gene Therapy|March 5, 2005
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancerRae Myers, Suzanne Greiner, Mary Harvey, et al.
The Journal of Infectious Diseases|June 8, 2004
Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccineRichard L Ward, David I Bernstein, Vicki E Smith, et al.
Plos One|June 21, 2011
Immunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in miceGe Liu, Bart Tarbet, Langzhou Song, et al.
Vaccine|July 17, 2012
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune responseDavid N Taylor, John J Treanor, Eric A Sheldon, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Nanopore molecular trajectories of a eukaryotic reverse transcriptase reveal a long-range RNA structure sensing mechanismAlan Shaw, Jonathan M Craig, Hossein Amiri, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Nature Methods|July 7, 2014
Spatial control of membrane receptor function using ligand nanocalipersAlan Shaw, Vanessa Lundin, Ekaterina Petrova, et al.
Nature Nanotechnology|January 16, 2019
Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodiesAlan Shaw, Ian T Hoffecker, Ioanna Smyrlaki, et al.
Nature Nanotechnology|February 21, 2019
Publisher Correction: Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodiesAlan Shaw, Ian T Hoffecker, Ioanna Smyrlaki, et al.
Vaccine|October 26, 2010
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adultsJohn J Treanor, David N Taylor, Lynda Tussey, et al.
Virology|January 22, 2005
Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse modelLeigh Zerboni, Stewart Hinchliffe, Marvin H Sommer, et al.
Cancer Gene Therapy|March 5, 2005
Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancerRae Myers, Suzanne Greiner, Mary Harvey, et al.
The Journal of Infectious Diseases|June 8, 2004
Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccineRichard L Ward, David I Bernstein, Vicki E Smith, et al.
Plos One|June 21, 2011
Immunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in miceGe Liu, Bart Tarbet, Langzhou Song, et al.
Vaccine|July 17, 2012
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune responseDavid N Taylor, John J Treanor, Eric A Sheldon, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Nanopore molecular trajectories of a eukaryotic reverse transcriptase reveal a long-range RNA structure sensing mechanismAlan Shaw, Jonathan M Craig, Hossein Amiri, et al.
Pageof 4